David Armstrong

David Armstrong's AcademicInfluence.com Rankings

David Armstrong

Philosophy

#9936

World Rank

#13568

Historical Rank

Logic

#6889

World Rank

#8447

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David Armstrong's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences Johns Hopkins University

Why Is David Armstrong Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Armstrong's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification (1999) (2034)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. (2015) (1114)
The endoscopic assessment of esophagitis: a progress report on observer agreement. (1996) (997)
The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. (2006) (957)
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting (2004) (395)
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. (2012) (383)
Infection with Helicobacter pylori. (1996) (355)
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study (2003) (310)
Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. (2017) (282)
Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity (2009) (278)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes (2013) (247)
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. (2005) (247)
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. (1995) (213)
EUS: a meta-analysis of test performance in suspected choledocholithiasis. (2008) (200)
Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis (2014) (169)
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori (2000) (160)
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. (1995) (157)
CMOS Image Sensors for High Speed Applications (2009) (153)
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs (2004) (151)
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study (2005) (151)
Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. (1994) (142)
World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. (2017) (133)
A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastroesophageal Reflux Disease: One-Year Follow-Up (2006) (116)
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months (2002) (114)
A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study (2005) (113)
Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. (2012) (111)
Simple clinical predictors may obviate urgent endoscopy in selected patients with nonvariceal upper gastrointestinal tract bleeding. (2007) (107)
The role of acid suppression in patients with endoscopy‐negative reflux disease: the effect of treatment with esomeprazole or omeprazole (2004) (101)
Helicobacter pylori infection and dyspepsia. (1996) (92)
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. (2000) (91)
Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. (2005) (89)
Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials (2006) (89)
Endoscopic evaluation of gastro-esophageal reflux disease. (1999) (86)
Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study 1 (2005) (86)
A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes (2011) (85)
Topical Metronidazole (10 Percent) Decreases Posthemorrhoidectomy Pain and Improves Healing (2004) (85)
Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia (2004) (82)
Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers (2005) (80)
Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting. (2006) (79)
Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial (2006) (79)
Convolutional neural networks for medical image analysis: State-of-the-art, comparisons, improvement and perspectives (2021) (78)
Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. (1996) (78)
Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. (2017) (75)
Evaluation and management of skeletal health in celiac disease: position statement. (2012) (74)
Endoscopic features of Helicobacter pylori-related gastritis. (1995) (72)
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. (1997) (66)
Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. (2004) (65)
Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study (2006) (60)
Review article: gastric pH — the most relevant predictor of benefit in reflux disease? (2004) (60)
Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. (1993) (58)
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus (2017) (56)
Heartburn‐dominant, uninvestigated dyspepsia: a comparison of ‘PPI‐start’ and ‘H2‐RA‐start’ management strategies in primary care – the CADET‐HR Study (2005) (55)
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. (2001) (55)
Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia (2004) (52)
Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients. (2007) (52)
Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. (1998) (52)
Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. (2007) (51)
Nocturnal oesophageal motor activity is dependent on sleep stage. (1993) (50)
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z (2008) (50)
Predictors of treatment response in patients with non‐erosive reflux disease (2006) (48)
Access to specialist gastroenterology care in Canada: comparison of wait times and consensus targets. (2008) (48)
Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. (2011) (47)
Measuring Quality of Care in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage: Development of an Explicit Quality Indicator Set (2010) (47)
Access to specialist gastroenterology care in Canada: the Practice Audit in Gastroenterology (PAGE) Wait Times Program. (2008) (45)
An Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Esophagus-Related Neoplasia. (2019) (45)
The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy (2006) (45)
Reproducibility of long-term ambulatory esophageal combined pH/manometry. (1991) (45)
Economic analysis of home vs hospital-based parenteral nutrition in Ontario, Canada. (2005) (45)
Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base. (2007) (44)
Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers. (1994) (42)
The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial (2010) (41)
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. (2003) (41)
Systematic review: persistence and severity in gastro‐oesophageal reflux disease (2008) (40)
Canadian credentialing guidelines for colonoscopy. (2008) (40)
The 2012 SAGE wait times program: Survey of Access to GastroEnterology in Canada. (2013) (39)
Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation. (2011) (39)
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease Figure 1 (2001) (39)
The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts. (1998) (38)
What is the role of endoscopy and oesophageal biopsies in the management of GERD? (2013) (38)
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection (2000) (38)
Reflux disease and Barrett's oesophagus. (1994) (36)
Efficacy of Topical Metronidazole (10 Percent) in the Treatment of Anorectal Crohn’s Disease (2005) (36)
The pharmacodynamics and pharmacokinetics of S‐tenatoprazole‐Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects (2010) (36)
Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis. (2000) (36)
Influence of stress on the healing and relapse of duodenal ulcers. A prospective, multicenter trial of 2109 patients with recurrent duodenal ulceration treated with ranitidine. RUDER Study Group. (1992) (35)
Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry (2018) (35)
Reproducibility of ambulatory gastric pH recordings in the corpus and antrum. Effect of food, time, and electrode position. (1990) (34)
A Randomized Multicenter Trial to Evaluate Simple Utility Elicitation Techniques in Patients With Gastroesophageal Reflux Disease (2004) (33)
A literature review of quality in lower gastrointestinal endoscopy from the patient perspective. (2011) (33)
The effect of intra‐gastric acidity and flora on the concentration of N‐nitroso compounds in the stomach (2000) (33)
Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects (2003) (32)
Canadian credentialing guidelines for endoscopic retrograde cholangiopancreatography. (2008) (32)
Do physicians correctly assess patient symptom severity in gastro‐oesophageal reflux disease? (2004) (32)
Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable (2010) (31)
Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis. (2008) (31)
Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects (2006) (31)
Changes in Home Parenteral Nutrition Practice Based on the Canadian Home Parenteral Nutrition Patient Registry (2017) (30)
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease. (2018) (30)
Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire (2007) (29)
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD) (2012) (29)
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease (2005) (28)
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents (2017) (28)
Addition of glutamine to essential amino acids and carbohydrate does not enhance anabolism in young human males following exercise. (2006) (28)
Oesophageal pH-metry: should meals be standardized? (1992) (27)
WGO Guidance for the Care of Patients With COVID-19 and Liver Disease (2020) (27)
A Comparison of Narrative and Table Formats for Presenting Hypothetical Health States to Patients with Gastrointestinal or Pulmonary Disease (2004) (26)
Origins of motility patterns in isolated arterially perfused rat intestine. (1994) (26)
Epidemiology and risk factors for bloodstream infections in a home parenteral nutrition program. (2015) (26)
Pantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn: A Prospective, Randomized, Double Blind Comparative Study With Nizatidine (2003) (25)
Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease (2018) (25)
Malnutrition Matters in Canadian Hospitalized Patients: Malnutrition Risk in Hospitalized Patients in a Tertiary Care Center Using the Malnutrition Universal Screening Tool. (2015) (24)
Clinical Practice Guidelines for the Assessment of Uninvestigated Esophageal Dysphagia (2018) (23)
Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. (2005) (23)
13C urea breath test for (Helicobacter pylori): determination of the optimal cut-off point in a Canadian community population. (2006) (23)
The origin of nocturnal intragastric pH rises in healthy subjects. (1995) (23)
Development of a catadioptric endoscope objective with forward and side views. (2011) (22)
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study. (2019) (22)
929c A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis. (2014) (22)
Evaluation of densitometric bone-muscle relationships in Crohn's disease. (2007) (21)
Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial (2013) (21)
High Concentrations of Ammonia, But Not Volatile Amines, in Gastric Juice of Subjects with Helicobacter pylori Infection (1998) (21)
Point-of-care, peer-comparator colonoscopy practice audit: The Canadian Association of Gastroenterology Quality Program--Endoscopy. (2011) (21)
Diclofenac delays healing of gastroduodenal mucosal lesions (1991) (20)
Intravenous proton pump inhibitor therapy: a rationale for use. (2005) (20)
Summary of guidelines for infection prevention and control for flexible gastrointestinal endoscopy. (2013) (20)
Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms. (1997) (20)
Canadian credentialing guidelines for endoscopic privileges: an overview. (2007) (20)
Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures: multidisciplinary task force report. (2013) (19)
Indicators of safety compromise in gastrointestinal endoscopy. (2012) (19)
Gluten-free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Anti-gliadin IgG. (2020) (19)
GERD and obesity: is the autonomic nervous system the missing link? (2014) (18)
Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? (1992) (18)
Prevalence of Helicobacter pylori infection in children in the Bahamas. (2012) (17)
Egyptian recommendations for management of Helicobacter pylori infection: 2018 report. (2019) (17)
Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study (2009) (17)
Practice Audit in Gastroenterology (PAGE) program: a novel approach to continuing professional development. (2006) (17)
New pharmacologic approaches in gastroesophageal reflux disease. (2010) (17)
Association Between Age and Complications After Outpatient Colonoscopy (2020) (17)
Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. (2007) (16)
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole (2005) (16)
Esomeprazole 40mg and 20mg is efficacious in the long-term management of patients with endoscopy-negative gerd: A placebo-controlled trial of on-demand therapy for 6 months (2000) (16)
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey (2020) (16)
Novel pharmaceutical approaches to reflux disease. (2013) (16)
Gastroesophageal reflux disease. (2005) (15)
Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group. (1993) (15)
Quality indicators for colonoscopy: The road forward. (2014) (15)
Associations Between Colonic Motor Patterns and Autonomic Nervous System Activity Assessed by High-Resolution Manometry and Concurrent Heart Rate Variability (2020) (14)
Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease (2000) (14)
Patient-identified quality indicators for colonoscopy services. (2013) (14)
Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease (2019) (14)
Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis – results from the EXPO study (2009) (14)
Approaches of integrating the development of guidelines and quality indicators: a systematic review (2020) (13)
The effect of continuous enteral nutrition on gastric acidity in humans. (1992) (13)
Juvenile onset of Crohn's disease: a risk factor for reduced lumbar bone mass in premenopausal women. (2007) (13)
Validation of a symptom diary for patients with gastro‐oesophageal reflux disease (2006) (13)
Canadian credentialing guidelines for esophagogastroduodenoscopy. (2008) (13)
Are endoscopy negative GERD and reflux esophagitis different diseases? Baseline histology in GERD patients off-therapy — the CHEER study (2003) (12)
The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care (2013) (12)
13C urea breath test for (Helicobacter pylori): evaluation of 10-minute breath collection. (2006) (12)
Ambulatory Esophageal Manometry: Comparison of Expert and Computer‐Aided Analyses (1990) (12)
The Canadian Home Total Parenteral Nutrition (HTPN) Registry: vitamin K supplementation and bone mineral density. (2012) (12)
A survey of the practice of after-hours and emergency endoscopy in Canada. (2012) (12)
Personal Protective Equipment for Endoscopy in Low-Resource Settings During the COVID-19 Pandemic: Guidance From the World Gastroenterology Organisation. (2020) (12)
An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease (2006) (12)
Helicobacter pylori and dyspepsia: a conceptual approach (1996) (12)
Barrett's esophagus: histology and immunohistology (2011) (11)
GERD Evaluation: Time for a New Paradigm? (2007) (11)
Should patients with Barrett's oesophagus be kept under surveillance? The case for. (2008) (11)
Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study (2019) (11)
Improving serological test ordering patterns for the diagnosis of celiac disease through clinical laboratory audit of practice. (2012) (11)
Safety of esophagogastroduodenoscopy within 30 days of myocardial infarction: a retrospective cohort study from a Canadian tertiary centre. (2012) (11)
Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. (2009) (10)
A Critical Assessment of the Current Status of Non-Erosive Reflux Disease (2008) (10)
Laparoscopic-Assisted Bowel Resection in Pediatric/Adolescent Inflammatory Bowel Disease: Laparoscopic Bowel Resection in Children (2003) (10)
A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care. (2010) (10)
Continuous measurement of rat gastric blood flow using Doppler flowmeter. (1993) (10)
Integrating Data from EHRs to Enhance Clinical Decision Making: The Inflammatory Bowel Disease Case (2014) (9)
Barrett's esophagus: proton pump inhibitors and chemoprevention II (2011) (9)
Esomeprazole therapy and esophageal histology in endoscopy-negative reflux disease (ENRD) — the CHEER study (2003) (9)
Uniting the global gastroenterology community to meet the challenge of climate change and non-recyclable waste (2021) (9)
The effect of sham feeding on neurocardiac regulation in healthy human volunteers. (2007) (9)
A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups (2018) (8)
The ROME II definition of dyspepsia does not exclude patients with gastroesophageal reflux disease (GERD) in primary care (2003) (8)
Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes (2021) (8)
Reflux disease and Barrett's oesophagus. (1992) (8)
A low resting vagal tone predicts response to acid perfusion in patients with esophageal symptoms (1996) (8)
Canadian credentialing guidelines for flexible sigmoidoscopy. (2008) (7)
Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Non-Recyclable Waste. (2021) (7)
Maintenance therapy: Is there still a place for antireflux surgery? (1992) (7)
Is prempt endoscopy necessary in uninvestigated dyspeptics? Prevalence of upper Gastrointestinal abnormalities — The CADET-PE study (2001) (7)
Tu2033 Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial (2014) (7)
The prevalence of Barrett's esophagus in primary care patients with uninvestigated dyspepsia (2003) (7)
Survival of Patients With Short Bowel Syndrome on Home Parenteral Nutrition: A Prospective Cohort Study. (2020) (7)
Motion - All patients with GERD should be offered once in a lifetime endoscopy: arguments for the motion. (2002) (7)
Getting fit for hip and knee replacement: a protocol for the Fit-Joints pilot randomized controlled trial of a multi-modal intervention in frail patients with osteoarthritis (2018) (7)
Reflux esophagitis and H. pylori. (1997) (7)
It is time to stop prescribing oral salbutamol. (2016) (7)
Effect of Omeprazole on Regional and Temporal Variations in Intragastric Acidity (2002) (7)
Famotidine should be taken with supper : the effect of drug-meal interactions on gastric acidity and plasma famotidine levels (1991) (7)
Latin american consensus on gastroesophageal reflux disease: an update on therapy. (2010) (7)
Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression. (1999) (7)
Effects of misoprostol on healing and prevention of biopsy‐induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers (1996) (6)
Proton pump inhibitors and gastric cancer: association is not causation (2018) (6)
Management of reflux esophagitis: does the choice of proton pump inhibitor matter? (2015) (6)
RUDER—A prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine (1994) (6)
Gastroesophageal reflux disease and pH monitoring (1991) (6)
Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice. (2002) (6)
Barrett's Dysplasia Cancer Task Force – Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus (2011) (6)
5-aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett’s esophagus cellular models (2015) (5)
Variations in practice patterns for adult cancer patients on home parenteral nutrition in Canada. (2019) (5)
M1079 Improving Adherence to Guidelines When Managing Non-Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Strategy (2010) (5)
Evaluation of the efficacy and performance of medical implants: a review. (2010) (5)
Deep Learning in Gastrointestinal Endoscopy. (2016) (5)
Effect of curing Helicobacter pylori (HP) infection on intragastric pH during omeprazole treatment (1995) (5)
Endoscopic Classification of Reflux Esophagitis by the MUSE System (1997) (5)
Recent trends in breast, cervical, and colorectal cancer screening test utilization in Canada, using self-reported data from 2008 and 2012. (2015) (5)
Symptom Assessment: Methods and Content (2007) (5)
W1096 The Gamma-Aminobutyric Acid (GABA) Receptor Agonist Baclofen in the Treatment of Gastroesophageal Reflux Disease (GERD): A Systematic Review (2010) (5)
Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Nonrecyclable Waste. (2021) (5)
Endoscopic Ultrasound: A Meta-Analysis of Test Performance in Suspected Choledocholithiasis (2007) (5)
A double-blind randomised controlled trial comparing omeprazole, ranitidine, cisapride and placebo in 512 Helicobacter pylori (Hp) negative primary care patients with uninvestigated dyspepsia (UD)—the CADET HN study (2001) (5)
Does long‐term maintenance therapy with ranitidine affect the natural course of duodenal ulcer disease? (1993) (5)
Gastroesophageal reflux disease, pH monitoring, and treatment (1992) (5)
5-aminolevulinic acid for quantitative seek-and-treat of high-grade dysplasia in Barrett’s esophagus cellular models (2015) (4)
Symptom response at 1-week predicts responders at 4-weeks with esomeprazole (40 mg bid and od) in patients with uninvestigated dyspepsia (2003) (4)
Guideline-based quality assurance: a conceptual framework for the definition of key elements (2021) (4)
Peripheral Intravenous Infusion of Potassium Chloride: Effect of Solution Composition on Infusion-Site Pain (2004) (4)
PGI9 RESPONSIVENESS TO CHANGE AND ENGLISH LANGUAGE VALIDATION OF THE WPAI-GERD QUESTIONNAIRE-RESULTS FROM A CANADIAN STUDY (2004) (4)
Pharmacist-specific guidelines for the medical management of GERD in adults* (2008) (3)
564 Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis Than the Lichtiger Index, CRP or Blood Leukocytes (2012) (3)
Report on the expert forum on using information technology to facilitate uptake and impact of colorectal cancer screening guidelines. (2012) (3)
Symptom response at one week to predict outcome at four weeks with esomeprazole (E) in heartburn-dominant uninvestigated dyspepsia (HBDUD) patients: The confirmatory acid suppression test (CAST) study (2003) (3)
Rio de Janeiro Global Consensus on Landmarks, Definitions and Classifications in Barrett's Esophagus: World Endoscopy Organization Delphi Study. (2022) (3)
Prospective multicentre study ofrisk factors associated withdelayed healing ofrecurrent duodenal ulcers (RUDER) (1993) (3)
Endoscopy and quality assurance – It is here! (2007) (3)
59 A Novel, Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Oesophagus Related Neoplasia (Born): The Born Project (2017) (3)
Integrated CMOS sensors for fluorescence spectroscopy and imaging (2009) (3)
Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist (2022) (3)
Epidemiology of GERD, Barrett's esophagus and esophageal cancer. (2014) (3)
Anxiety, Depression and Quality of Life Improve After One Month and Three Months of Home Parenteral Nutrition: A Pilot Study in a Canadian Population (2018) (3)
S1092 Gastroesophageal Reflux Disease - a Chronic, Persistent Disease: A Systematic Review of the Literature (2008) (3)
Antigliadin Antibodies Predict the Symptomatic Response to Gluten-Free Diet and Improvement in Gastrointestinal Motility in IBS Patients (2017) (3)
Global Perspective on Gastroesophageal Reflux Disease (2017) (3)
Early evening nizatidine intake with a meal optimizes the antisecretory effect (1993) (3)
A303 SIMULTANEOUS PRESSURE WAVES ARE A KEY COMPONENT OF HUMAN COLON MOTOR FUNCTION ASSESSMENT, USING HIGH-RESOLUTION COLONIC MANOMETRY (HRCM) (2018) (3)
Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group. (1995) (3)
[Effect of the menstrual cycle on the reproducibility of anorectal manometry]. (1994) (3)
Optical Biopsy of the Upper GI Tract Using Fluorescence Lifetime and Spectra (2020) (3)
Fate of antacid gel in the stomach. Site of action and interaction with food. (1990) (2)
Gastroesophageal reflux disease (GERD) symptoms (GS) in 5 European countries: A common and poorly understood condition (2001) (2)
Diarrhea during critical illness: a multicenter cohort study (2022) (2)
Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist (2016) (2)
Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease (2019) (2)
Helicobacter pylori infection and omeprazole efficacy. (1996) (2)
Computer-assisted ambulatory long-term manometry of tubular esophagus (1991) (2)
The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions. (2021) (2)
M1018 Quality Indicators for Colonoscopy in Canada: the Canadian Association of Gastroenterology (cag) Endoscopy Quality Initiative (EQI) Practice Audit Project (2009) (2)
P-119 Transition Experience from Pediatric to Adult IBD Care: Results of a Pilot Study (2013) (2)
Predictors of treatment response and relapse for heartburn-dominant uninvestigated dyspepsia (HBDUD) in primary care practice (PCP): the CADET-HR study (2002) (2)
Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication (2018) (2)
Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia (2017) (2)
A multinational survey of activities of daily living and GERD in clinical practice: Is prescription therapy adequate? (2003) (2)
P-079 YI The Association Between Anxiety and Depression and Health Related Quality of Life in Patients with Inflammatory Bowel Disease (IBD) (2016) (2)
Initial management strategies for reflux-predominant uninvestigated dyspepsia (UD) in primary care practice-the CADET-HR study (2001) (2)
AGN 201904-Z (AGN), a Novel Enteric-Coated PPI, Produces Greater, More Prolonged Acid Suppression Than Esomeprazole (ESO) in Healthy Male Volunteers: 149 (2006) (2)
Canadian Association of Gastroenterology: Strategic Plan 2016–2020 (2016) (1)
Tu1642 – Validation of the Bristol Stool Chart and the Bliss Stool Classification System in the Intensive Care Unit (2019) (1)
New pharmacologic approaches in gastroesophageal reflux disease. (2011) (1)
Mucosal Features of Colonic Crohn’s Disease Determined by Confocal Laser Endomicroscopy (CLE): An Inter-observer Agreement Study: 1714 (2014) (1)
Home parenteral nutrition patients on mixed oil lipid emulsion have a higher rate of hospitalizations compare to those on soybean oil- a prospective 2-year cohort study. (2021) (1)
Proton pump inhibitor versus placebo in the short term management of gastro‐esophageal reflux disease (2013) (1)
A284 CHARACTERIZING SIMULTANEOUS PRESSURE WAVES IN THE HUMAN COLON BY HIGH-RESOLUTION MANOMETRY (2018) (1)
Update from the Canadian Dyspepsia Working Group. (2000) (1)
Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease. (2021) (1)
Mo1197 Dermatological Complications of Anti-TNF-a Therapy in Crohn's Disease (2014) (1)
The Canadian Association of Gastroenterology Strategic Plan: Where Are We in 2014? (2014) (1)
Sa1085 Telephone vs. Clinic Follow-Up in the Management of Patients With Inflammatory Bowel Disease: A Nurse Practitioner Led Study (2016) (1)
A67 RAPID REDUCTION IN ANXIETY SCORES IN IBD PATIENTS AFTER INFLIXIMAB INFUSION IS ASSOCIATED WITH CHANGES IN KYNURENINE/TRYPTOPHAN METABOLISM (2018) (1)
Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial (2020) (1)
Does Helicobacter pylori infection and its eradication have any effect on heartburn and gastroesophageal reflux? (2004) (1)
Corrigendum to “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement” (2017) (1)
M1890 Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care (2009) (1)
M1021 Endoscopy Unit Quality Indicators for Colonoscopy: the Canadian Association of Gastroenterology (cag) Endoscopy Quality Initiative (EQI) Practice Audit Project (2009) (1)
The cost-effectiveness of alternative strategies to manage patients with uninvestigated dyspepsia: comparing the CanDys approach to antisecretory therapy and prompt endoscopy (2003) (1)
M1870 Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care (2009) (1)
Knowledge gaps in the management of refractory reflux‐like symptoms: Healthcare provider survey (2022) (1)
Training in Gastrointestinal Endoscopy in Canada: A Survey of Program Directors in Gastroenterology (2004) (1)
Does Helicobacter pylori infection predict clinically significant findings at endoscopy in patients with uninvestigated dyspepsia ? The CADET-PE study (2002) (1)
754 - Survival of Patients with Short Bowel Syndrome on Home Parenteral Nutrition: Results from a National Registry (2018) (1)
Home parenteral nutrition in older versus younger patients: Clinical characteristics and outcomes. (2021) (1)
IMPACT OF RACE AND GENDER ON OUTPATIENT ENDOSCOPY PROCEDURES DURING COVID: RESULTS FROM A LARGE POPULATION-BASED SURVEY (2022) (1)
Bariatric Surgery and Its Effects on Heart Rate Variability (2016) (1)
Response to Dr. McColl et al . (2001) (0)
S390 Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial (2022) (0)
A233 BASELINE BOWEL ROUTINE AND OTHER PREDICTORS OF BOWEL PREPARATION IN PATIENTS UNDERGOING OUT-PATIENT COLONOSCOPY; RESULTS FROM A PROSPECTIVE SINGLE-CENTRE STUDY. (2019) (0)
Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study (2021) (0)
Mo1623: FOODS OR FADS? OUTCOMES OF KETOGENIC, PLANT-BASED, AND INTERMITTENT FASTING DIETS: A SYSTEMATIC REVIEW AND METAANALYSIS (2022) (0)
A250 NUTRISUP-PPN; PILOT RANDOMIZED CONTROL TRIAL OF ORAL AND PARENTERAL NUTRITION IN MALNOURISHED HOSPITALIZED PATIENTS (2022) (0)
A175 HOME PARENTERAL NUTRITION (HPN): INDICATIONS FOR THERAPY AND OUTCOMES FOR PATIENTS IN A SINGLE-CENTRE, CANADIAN HPN PROGRAM (1996–2018). (2019) (0)
Tu1034: SYMPTOM PROFILE, PPI THERAPY, AND DIAGNOSTIC TESTING IN PATIENTS WITH REFRACTORY GERD – RESULTS FROM A POPULATIONBASED SURVEY (2022) (0)
1090: ADDING DEAMIDATED GLIADIN PEPTIDE TO TISSUE TRANSGLUTAMINASE ANTIBODIES DOES NOT INCREASE CELIAC DISEASE DETECTION RATES IN IMMUNOGLOBULIN A (IGA) SUFFICIENT PATIENTS. (2022) (0)
1022 IS COLORECTAL CANCER SCREENING OR SURVEILLANCE APPROPRIATE FOR OLDER ADULTS? A POPULATION-BASED STUDY OF COLONOSCOPY-RELATED HOSPITAL ADMISSIONS (2019) (0)
Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease (2021) (0)
A87 PERSPECTIVES ON DIET MODIFICATION TO MANAGE THEIR SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. A SCOPING REVIEW (2023) (0)
A287 HOME PARENTERAL NUTRITION FOR INDIVIDUALS WITH SHORT BOWEL SYNDROME SECONDARY TO CROHN’S DISEASE VERSUS OTHER ETIOLOGIES: A PROSPECTIVE COHORT STUDY (2023) (0)
A13 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY (2023) (0)
Su1840 – Higher Adalimumab Serum Levels Do Not Increase the Risk of Adverse Events in Patients with Inflammatory Bowel Disease (2019) (0)
Oral Rabeprazole 20 Mg Provides More Effective Acid Control Than IV Pantoprazole 40 Mg: 111 (2006) (0)
Lung Macrophages Accumulate Novel Cytosolic Inclusions With Vaping: A Case Report From an Asymptomatic Habitual Vaper (2020) (0)
Clearing the air: A crowd-sourced clinical review on the controversies and evidence regarding probiotics for the treatment of the irritable bowel syndrome (2021) (0)
Audit in Gastroenterology ( PAGE ) program : A novel approach to continuing professional development (2016) (0)
Endoscopy Training for GI Trainees: The Impact of a 2-Day Introductory Training Course On Cognitive Knowledge (2007) (0)
Fate of antacid gel in the stomach (1990) (0)
Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies (2016) (0)
Does Measuring Infliximab and Human Anti‐Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease Impact Clinical Management? A Canadian Experience.: P‐169 (2012) (0)
Mo1039 - The Prevalence of Celiac Disease is Increased in Patients with Barrett's Esophagus and is Associated with Early Development of Dysplasia (2018) (0)
Effect ofHelicobacter pylorn status onintragastric pHduring treatment withomeprazole (1995) (0)
M1887 The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial (2009) (0)
Point Prevalence of Malnutrition Risk in a Tertiary Care Academic Hospital: 319 (2012) (0)
RUDER: interim evaluation of a 2-year, multicentre study of risk factors for duodenal ulcer relapse. (1991) (0)
Factors that influence heartburn relapse in patients with reflux esophagitis (2006) (0)
Transition experience from inpatient to ambulatory IBD care : Results of a pilot study (2014) (0)
P-231 YI Patient Experience Living with Inflammatory Bowel Disease (2016) (0)
Response to Dr. McColl et al. (2001) (0)
Effects ofranitidine andcisapride onacid reflux and oesophageal motility inpatients withreflux oesophagitis: a24hourambulatory combined pH (1993) (0)
“Step-up” or step-down? A 4-week comparison of pantoprazole, 40 mg daily and nizatidine, 150 mg bid in symptomatic gastroesophageal reflux disease (GERD) (2000) (0)
Communicating Gastrointestinal Symptoms: The Patient's Challenge. (2018) (0)
Su2014 – Home Parenteral Nutrition Patients with Severe Dysmotility Disorder: A Prospective Cohort Study (2019) (0)
Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS (2022) (0)
GI Endoscopy Training: Validation of a Computer-Based Endoscopy Simulator (2007) (0)
When should the position of Z-line and hiatus be measured during upper gastrointestinal endoscopy (UGE)? (1995) (0)
Mo1039 Communicating Gastrointestinal (GI) Symptoms: the Patient's Challenge (2012) (0)
M1013 Predictors of Bowel Preparation Quality in Patients Undergoing Colonoscopy- a Preliminary Analysis (2008) (0)
Su1108: ASSESSING KNOWLEDGE GAPS IN THE MANAGEMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE (RGERD) (2022) (0)
Mo1378 Psychosocial Characteristics of Patients With IBD: Experience From the Mcmaster Interdisciplinary Clinic (2013) (0)
カナダで設定された非静脈瘤上部消化管出血からの転帰に対するロックオール・スコアリング・システムの検査 (2006) (0)
Tu1153 REDUCING ANXIETY IN PATIENTS UNDERGOING FIRST-TIME COLONOSCOPY: A PILOT AND FEASIBILITY STUDY FOR RANDOMIZED CONTROLLED TRIAL (2020) (0)
Su2026 – Home Parenteral Nutrition (HPN): Indications for Therapy and Outcomes for Patients in a Single-Centre Hpn Program (1996-2018) (2019) (0)
An Electronic Clinical Decision-Making Tool for Patients with Suspected Colorectal Cancer—Preliminary Evaluation in Patients Presenting with Rectal Bleeding (2019) (0)
Training in Gastrointestinal Endoscopy in Canada: A Survey of Trainees in Gastroenterology (2004) (0)
New Pharmacologic Approaches in Gastroesophageal Disease (2011) (0)
P309 Transition experience from inpatient to ambulatory IBD care: Results of a pilot study (2014) (0)
P544 Does measuring IFX and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease impact clinical management? A Canadian experience (2013) (0)
World Digestive Health DayWDHD May 29, 2015 : heartburn : a global perspective : message from the chair (2015) (0)
Su2025 – Should a Diagnosis of Cancer Preclude Home Parenteral Nutrition Therapy? (2019) (0)
PGS6: THE COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES IN THE MANAGEMENT OF PATIENTS WITH UNINVESTIGATED DYSPEPSIA (UD): COMPARING THE CANDYS APPROACH TO EMPIRICAL ANTISECRETORY THERAPY AND PROMPT ENDOSCOPY (2003) (0)
Session 4: Long-term medical management (2001) (0)
recommendations, and discussion outputs background, processes, terminology, Symptom evaluation in reflux disease: workshop (2009) (0)
Can canadian endoscopists predict lesions at upper GI endoscopy (EGD)? An evaluation of the ‘PAGE’ program (2003) (0)
A National Survey and Needs Assessment on Choices of Therapeutic Agents for Chronic Idiopathic Constipation and Constipation Predominant Irritable Bowel Syndrome: A Canadian Perspective: 1782 (2015) (0)
Factors that influence resolution of heartburn in patients with reflux esophagitis (2006) (0)
A316 CANADIAN CANCER PATIENTS ON HOME TOTAL PARENTERAL NUTRITION (HTPN): A 10-YEAR ASSESSMENT (2018) (0)
Su1444 Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia (2014) (0)
Su1853 CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY (2020) (0)
Measuring Quality of Care in Patients with Nonvariceal Upper GI Hemorrhage (NVUGIH): Development of An Explicit Quality Indicator Set (2009) (0)
Practice audit in gastroEnterology—The PAGE program for upper GI endoscopy (EGD) (2003) (0)
Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease (2020) (0)
Epidemiology of Blood Stream Infections in a Hospital-Based, Home Parenteral Nutrition Program: 283 (2009) (0)
Interdisciplinary, prompt access IBD clinic: The hamilton health science experience: O-15. (2011) (0)
Symptom relief in gastroesophageal reflux disease (GERD): pantoprazole V nizatidine in a mixed patient population with endoscopy negative reflux disease (ENRD) and erosive esophagitis (EE) (2000) (0)
Peptic ulcer disease (2022) (0)
W1029 Information Needs of Digestive Disease Patients: the Patient Education Needs Survey (PENS) (2009) (0)
Tu1833 – Week 2 Adalimumab Level Predicts Short-Term Clinical Remission in Patients with Ibd (2019) (0)
Tu1467 INCREASED ENERGY EXPENDITURE AND REDUCED EXERCISE CAPACITY SUGGESTS IMPAIRED NUTRITIONAL STATUS IN CELIAC DISEASE PATIENTS ON A GLUTEN FREE DIET. (2020) (0)
Stomach and duodenum (1998) (0)
S1351 Clinical Outcomes of Adult Patients With Short Bowel Syndrome Treated With Teduglutide: A 2-year Cohort Study From the Canadian Home Parenteral Nutrition Registry (2021) (0)
P-121 Transition Experience from Inpatient to Ambulatory IBD Care: Results of a Pilot Study (2013) (0)
A312 POST MARKET USE OF TEDUGLUTIDE IN CANADA IN PATIENTS WITH SHORT BOWEL SYNDROME ON HOME PARENTERAL NUTRITION: THE REAL WORLD SETTING (2018) (0)
A297 FREQUENT ADVERSE CHILDHOOD EVENTS IN PATIENTS WITH IBS AND ORGANIC GASTROINTESTINAL DISORDERS (2018) (0)
Omeprazole efficacy and Helicobacter pylori infection. (1998) (0)
[Prevention of recurrence of ulcer disease: indications and choice of procedure]. (1992) (0)
Association of family history of gastric cancer, intestinal metaplasia and high gastric juice ammonia in patients with Helicobacter pylori infection (2000) (0)
Evaluation of a Novel, Icon-Based Symptom Assessment Tool for Gastroenterology: 1775 (2015) (0)
2885 Reducing Anxiety in Patients Undergoing First-Time Colonoscopy: A Pilot and Feasibility Study for a Randomized Controlled Trial (2019) (0)
Current Management Practices for Moderate‐To‐Severe Gastroesophageal Reflux Disease (GERD) in Canadian Primary Care Practice: 1487 (2012) (0)
Survey of Home Parenteral Nutrition Programs in Canada (2016) (0)
The following recommendations for pharmacists in the management and follow-up of patients with GERD are based on the most recent Canadian Consensus Conference on GERD management.1 I. Assessment and diagnosis of GERD (2008) (0)
The test and treat strategy for dyspepsia: Cost-effectiveness of the order of eradication strategies (2000) (0)
A321 CANADIAN HOME TOTAL PARENTERAL NUTRITION REGISTRY: 10 YEARS OF DATA ENTRY (2018) (0)
Su1897 Inflammation-Related Differences in Mucosa-Associated Microbiota and Paracellular Permeability in Crohn's Colitis (2016) (0)
Hospital-Based Parenteral Nutrition in Ontario, Canada vs Economic Analysis of Home (2009) (0)
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy]. (1995) (0)
A196 DIARRHEA AS A PRESENTING SYMPTOM OF RELAPSED GRANULOMATOSIS WITH POLYANGIITIS (2022) (0)
Highlights of the Canadian Frailty Network (CFN) Highly Qualified Personnel Poster Session (2019) (0)
Fr065 FECAL IMMUNOCHEMICAL TEST (FIT) VERSUS CY(CY) IN DETECTING ADVANCED COLON NEOPLASIA: A DIAGNOSTIC TEST ACCURACY META-ANALYSIS INCLUDING A HEAD-TO-HEAD COMPARISON OF FIT AND CY. (2021) (0)
P0363 / #645: AN INFORMATICS APPROACH TO IMPROVE THE EFFICIENCY OF CLINICAL BIG-DATA MANAGEMENT AND EXTRACTED DATA QUALITY FOR CLINICAL TRIALS: A SCOTTISH PICU’S PERSPECTIVE. (2021) (0)
S326 Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-Analysis (2021) (0)
A112 VIDEO CAPSULE ENDOSCOPY REGISTRY OF ONTARIO (VCERO) - RETROSPECTIVE PHASE (NORTHERN ONTARIO REGION) (2022) (0)
A296 A RHYTHMIC MOTOR PATTERN ASSOCIATED WITH HIGH AMPLITUDE PRESSURE WAVES IN HUMAN HIGH-RESOLUTION COLONIC MANOMETRY (2018) (0)
P135 Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, CRP or blood leukocytes (2012) (0)
A149 EARLY LIFE EVENTS IN PATIENTS WITH CELIAC DISEASE ARE COMMON AND ASSOCIATE WITH SEVERITY OF CONSTIPATION IN ADULTHOOD. (2019) (0)
Response to Atreja et al. (2011) (0)
A real-time endoscope tip motion tracker (2021) (0)
Tu1138 The BORN Project: A Novel, Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Oesophagus Related Neoplasia (BORN) (2016) (0)
A287 REACTIVITY OF THE EXTRINSIC AUTONOMIC NERVOUS SYSTEM ASSOCIATED WITH HUMAN COLONIC MOTOR PATTERNS (2018) (0)
Photodynamic Therapy (PDT) for Barrett's Esophagus with High-Grade Dysplasia (BE + HGD): Cost-Effectiveness Model with Probabilistic Sensitivity Analysis (2004) (0)
A240 HOME PARENTERAL NUTRITION IN OLDER VERSUS YOUNGER PATIENTS: CLINICAL CHARACTERISTICS AND OUTCOMES (2021) (0)
A194 PRESENCE OF CELIAC DISEASE IN PATIENTS WITH BARRETT’S ESOPHAGUS IS ASSOCIATED WITH FASTER DEVELOPMENT OF DYSPLASIA AND HIGHER RATES OF ESOPHAGEAL ADENOCARCINOMA (2020) (0)
A288 ANAL SPHINCTER RELAXATION ASSOCIATED WITH THE DEFECATION REFLEX AND GAS EXPULSION, ASSESSED BY HIGH-RESOLUTION COLONIC MANOMETRY (2018) (0)
Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity (2023) (0)
Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients. (2022) (0)
Patients’ Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach (2021) (0)
Su1860 HIGHER VEDOLIZUMAB SERUM LEVELS DO NOT INCREASE THE RISK OF ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2020) (0)
The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development (2022) (0)
Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia (2023) (0)
A192 CONSUMPTION OF FOOD LOWER IN TRYPTOPHAN IS ASSOCIATED WITH SIGNIFICANT ANXIETY IN PATIENTS WITH CELIAC DISEASE (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David Armstrong?

David Armstrong is affiliated with the following schools:

McMaster University
Stanford University
Johns Hopkins University
University of California, San Francisco